Logo image of BALY

BALLY'S CORP (BALY) Stock Fundamental Analysis

NYSE:BALY - US05875B3042 - Common Stock

9.95 USD
-0.05 (-0.5%)
Last: 8/29/2025, 8:07:38 PM
9.95 USD
0 (0%)
After Hours: 8/29/2025, 8:07:38 PM
Fundamental Rating

2

BALY gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 134 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of BALY have multiple concerns. While showing a medium growth rate, BALY is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year BALY has reported negative net income.
BALY had a positive operating cash flow in the past year.
In the past 5 years BALY always reported negative net income.
BALY had a positive operating cash flow in each of the past 5 years.
BALY Yearly Net Income VS EBIT VS OCF VS FCFBALY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

BALY's Return On Assets of -7.42% is on the low side compared to the rest of the industry. BALY is outperformed by 81.34% of its industry peers.
With a Return On Equity value of -91.83%, BALY is not doing good in the industry: 67.16% of the companies in the same industry are doing better.
BALY has a worse Return On Invested Capital (0.57%) than 76.87% of its industry peers.
Industry RankSector Rank
ROA -7.42%
ROE -91.83%
ROIC 0.57%
ROA(3y)-6.39%
ROA(5y)-4.24%
ROE(3y)-639.86%
ROE(5y)-385.68%
ROIC(3y)N/A
ROIC(5y)N/A
BALY Yearly ROA, ROE, ROICBALY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

BALY's Operating Margin of 1.99% is on the low side compared to the rest of the industry. BALY is outperformed by 73.88% of its industry peers.
BALY has a better Gross Margin (54.78%) than 66.42% of its industry peers.
In the last couple of years the Gross Margin of BALY has declined.
Industry RankSector Rank
OM 1.99%
PM (TTM) N/A
GM 54.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.11%
GM growth 5Y-3.47%
BALY Yearly Profit, Operating, Gross MarginsBALY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

0

2. Health

2.1 Basic Checks

BALY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
BALY has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BALY has been increased compared to 5 years ago.
BALY has a worse debt/assets ratio than last year.
BALY Yearly Shares OutstandingBALY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BALY Yearly Total Debt VS Total AssetsBALY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.26, we must say that BALY is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.26, BALY is not doing good in the industry: 82.84% of the companies in the same industry are doing better.
A Debt/Equity ratio of 5.65 is on the high side and indicates that BALY has dependencies on debt financing.
BALY has a worse Debt to Equity ratio (5.65) than 62.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.65
Debt/FCF N/A
Altman-Z 0.26
ROIC/WACC0.07
WACC8.18%
BALY Yearly LT Debt VS Equity VS FCFBALY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

BALY has a Current Ratio of 0.49. This is a bad value and indicates that BALY is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.49, BALY is doing worse than 76.12% of the companies in the same industry.
BALY has a Quick Ratio of 0.49. This is a bad value and indicates that BALY is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BALY (0.47) is worse than 73.88% of its industry peers.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.47
BALY Yearly Current Assets VS Current LiabilitesBALY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

BALY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.90%.
Looking at the last year, BALY shows a decrease in Revenue. The Revenue has decreased by -1.10% in the last year.
The Revenue has been growing by 36.16% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-33.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-203.23%
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y22.83%
Revenue growth 5Y36.16%
Sales Q2Q%5.77%

3.2 Future

Based on estimates for the next years, BALY will show a very strong growth in Earnings Per Share. The EPS will grow by 22.94% on average per year.
The Revenue is expected to grow by 6.76% on average over the next years.
EPS Next Y82.06%
EPS Next 2Y35.34%
EPS Next 3Y22.94%
EPS Next 5YN/A
Revenue Next Year3.43%
Revenue Next 2Y5.04%
Revenue Next 3Y6.76%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BALY Yearly Revenue VS EstimatesBALY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
BALY Yearly EPS VS EstimatesBALY Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BALY. In the last year negative earnings were reported.
Also next year BALY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BALY Price Earnings VS Forward Price EarningsBALY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BALY is valued a bit cheaper than the industry average as 66.42% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.42
BALY Per share dataBALY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 -60

4.3 Compensation for Growth

A more expensive valuation may be justified as BALY's earnings are expected to grow with 22.94% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.34%
EPS Next 3Y22.94%

0

5. Dividend

5.1 Amount

BALY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BALLY'S CORP

NYSE:BALY (8/29/2025, 8:07:38 PM)

After market: 9.95 0 (0%)

9.95

-0.05 (-0.5%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners79.72%
Inst Owner Change-0.21%
Ins Owners12.59%
Ins Owner Change2.17%
Market Cap488.74M
Analysts50.91
Price Target12.7 (27.64%)
Short Float %0.81%
Short Ratio3.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-712.79%
Min EPS beat(2)-1443.99%
Max EPS beat(2)18.41%
EPS beat(4)1
Avg EPS beat(4)-1094.62%
Min EPS beat(4)-2765.33%
Max EPS beat(4)18.41%
EPS beat(8)2
Avg EPS beat(8)-779.41%
EPS beat(12)2
Avg EPS beat(12)-863.1%
EPS beat(16)4
Avg EPS beat(16)-655.13%
Revenue beat(2)0
Avg Revenue beat(2)-2.3%
Min Revenue beat(2)-4.31%
Max Revenue beat(2)-0.29%
Revenue beat(4)0
Avg Revenue beat(4)-3.46%
Min Revenue beat(4)-5.87%
Max Revenue beat(4)-0.29%
Revenue beat(8)0
Avg Revenue beat(8)-3.49%
Revenue beat(12)0
Avg Revenue beat(12)-2.89%
Revenue beat(16)0
Avg Revenue beat(16)-4.47%
PT rev (1m)-8.79%
PT rev (3m)-23.38%
EPS NQ rev (1m)-53.41%
EPS NQ rev (3m)5.48%
EPS NY rev (1m)-26.89%
EPS NY rev (3m)-27.02%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)7.12%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.86%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF 9.24
P/B 0.78
P/tB N/A
EV/EBITDA 10.42
EPS(TTM)-11.1
EYN/A
EPS(NY)-1.97
Fwd EYN/A
FCF(TTM)-4.62
FCFYN/A
OCF(TTM)1.08
OCFY10.83%
SpS50.02
BVpS12.83
TBVpS-61.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.42%
ROE -91.83%
ROCE 0.72%
ROIC 0.57%
ROICexc 0.58%
ROICexgc 1.3%
OM 1.99%
PM (TTM) N/A
GM 54.78%
FCFM N/A
ROA(3y)-6.39%
ROA(5y)-4.24%
ROE(3y)-639.86%
ROE(5y)-385.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.11%
GM growth 5Y-3.47%
F-Score6
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 5.65
Debt/FCF N/A
Debt/EBITDA 9.52
Cap/Depr 85.99%
Cap/Sales 11.38%
Interest Coverage 0.16
Cash Conversion 14.15%
Profit Quality N/A
Current Ratio 0.49
Quick Ratio 0.47
Altman-Z 0.26
F-Score6
WACC8.18%
ROIC/WACC0.07
Cap/Depr(3y)125.58%
Cap/Depr(5y)105.92%
Cap/Sales(3y)17.68%
Cap/Sales(5y)13.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-203.23%
EPS Next Y82.06%
EPS Next 2Y35.34%
EPS Next 3Y22.94%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y22.83%
Revenue growth 5Y36.16%
Sales Q2Q%5.77%
Revenue Next Year3.43%
Revenue Next 2Y5.04%
Revenue Next 3Y6.76%
Revenue Next 5YN/A
EBIT growth 1Y260.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year386.31%
EBIT Next 3Y74.99%
EBIT Next 5YN/A
FCF growth 1Y18.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-68.67%
OCF growth 3Y11.25%
OCF growth 5Y3.91%